Skip to main content
Have a personal or library account? Click to login
Venous Thrombosis and Post-Thrombotic Syndrome: From Novel Biomarkers to Biology Cover

Venous Thrombosis and Post-Thrombotic Syndrome: From Novel Biomarkers to Biology

Open Access
|Jul 2018

References

  1. Benjamin EJ Blaha MJ Chiuve SE Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association Circulation 2017 135 10 e146 603
  2. Silverstein MD Heit JA Mohr DN Petterson TM O'Fallon WM Melton LJ 3rd Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study Arch Intern Med 1998 Mar 23 158 6 585 93
  3. Königsbrügge O Pabinger I Ay C Risk factors for venous thromboembolism in cancer: novel findings from the Vienna Cancer and Thrombosis Study (CATS) Thromb Res 2014 May 133 Suppl 2 S39 43
  4. Pannucci CJ Shanks A Moote MJ Identifying patients at high risk for venous thromboembolism requiring treatment after outpatient surgery Ann Surg 2012 Jun 255 6 1093 9
  5. Obi AT Pannucci CJ Nackashi A Validation of the Caprini Venous Thromboembolism Risk Assessment Model in Critically Ill Surgical Patients JAMA Surg 2015 Oct 150 10 941 8
  6. Kahn SR The post-thrombotic syndrome: the forgotten morbidity of deep venous thrombosis J Thromb Thrombolysis 2006 21 1 41 8
  7. ten Cate-Hoek AJ Henke PK Wakefield TW The post thrombotic syndrome: Ignore it and it will come back to bite you Blood Rev 2016 30 2 131 7
  8. Bergan JJ Schmid-Schonbein GW Smith PD Nicolaides AN Boisseau MR Eklof B Chronic venous disease N Engl J Med 2006 355 5 488 98
  9. Popuri RK Vedantham S The role of thrombolysis in the clinical management of deep vein thrombosis Arterioscler Thromb Vasc Biol 31 3 479 84
  10. Vedantham S Goldhaber SZ Julian JA Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis N Engl J Med 2017 377 23 2240 52
  11. Wakefield TW McLafferty RB Lohr JM Call to action to prevent venous thromboembolism J Vasc Surg 2009 49 6 1620 3
  12. Diaz JA Obi AT Myers DD Jr. Critical review of mouse models of venous thrombosis Arterioscler Thromb Vasc Biol 2012 32 3 556 62
  13. Zhou J May L Liao P Gross PL Weitz JI Inferior vena cava ligation rapidly induces tissue factor expression and venous thrombosis in rats Arterioscler Thromb Vasc Biol 2009 29 6 863 69
  14. Humphries J Gossage JA Modarai B Monocyte urokinase-type plasminogen activator up-regulation reduces thrombus size in a model of venous thrombosis J Vasc Surg 2009 50 5 1127 34
  15. Diaz JA Hawley AE Alvarado CM Thrombogenesis with continuous blood flow in the inferior vena cava. A novel mouse model Thromb Haemost 2010 104 2 366 75
  16. Cooley BC In vivo fluorescence imaging of large-vessel thrombosis in mice Arterioscler Thromb Vasc Biol 2011 31 6 1351 56
  17. Diaz JA Wrobleski SK Hawley AE Lucchesi BR Wakefield TW Myers DD Jr. Electrolytic inferior vena cava model (EIM) of venous thrombosis J Vis Exp 2011 53 e2737
  18. Meng H Yalavarthi S Kanthi Y In Vivo Role of Neutrophil Extracellular Traps in Antiphospholipid Antibody-Mediated Venous Thrombosis Arthritis Rheumatol a2017 69 3 655 7
  19. von Bruhl ML Stark K Steinhart A Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo J Exp Med 2012 209 4 819 5
  20. Rao AN Kazzaz NM Knight JS Do neutrophil extracellular traps contribute to the heightened risk of thrombosis in inflammatory diseases? World J Cardiol 2015 7 12 829 42
  21. Deroo S Deatrick KB Henke PK The vessel wall: A forgotten player in post thrombotic syndrome Thromb Haemost 2010 104 4 681 92
  22. Henke PK Wakefield T Thrombus resolution and vein wall injury: dependence on chemokines and leukocytes Thromb Res 2009 123 Suppl 4 S72 78
  23. Wakefield TW Myers DD Henke PK Mechanisms of venous thrombosis and resolution Arterioscler Thromb Vasc Biol 2008 28 3 387 91
  24. Takada M Nadeau KC Shaw GD Marquette KA Tilney NL The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand J Clin Invest 1997 99 11 2682 90
  25. Myers D Jr. Farris D Hawley A Selectins influence thrombosis in a mouse model of experimental deep venous thrombosis J Surg Res 2002 108 2 212 21
  26. Sullivan VV Hawley AE Farris DM Decrease in fibrin content of venous thrombi in selectin-deficient mice J Surg Res 2003 109 1 1 7
  27. Vandy F Stabler C Eliassen A Soluble P-selectin for the diagnosis of lower extremity deept venous thrombosis Journal of Vascular Surgery 2013 1 117 25
  28. Timp JF Lijfering WM Flinterman LE Predictive value of factor VIII levels for recurrent venous thrombosis: results from the MEGA follow-up study J Thromb Haemost 2015 13 10 1823 32
  29. Frank PG Lisanti MP ICAM-1: role in inflammation and in the regulation of vascular permeability Am J Physiol Heart Circ Physiol 2008 295 3 H926 7
  30. Isogai N Tanaka H Asamura S Thrombosis and altered expression of intercellular adhesion molecule-1 (ICAM-1) after avulsion injury in rat vessels J Hand Surg Br 2004 29 3 230 4
  31. Darbousset R Thomas GM Mezouar S Tissue factor-positive neutrophils bind to injured endothelial wall and initiate thrombus formation Blood 2012 120 10 2133 43
  32. Obi AT Andraska E Kanthi Y Endotoxaemia-augmented murine venous thrombosis is dependent on TLR-4 and ICAM-1, and potentiated by neutropenia Thromb Haemost 2017 117 2 339 48
  33. Smith A Quarmby JW Collins M Lockhart SM Burnand KG Changes in the levels of soluble adhesion molecules and coagulation factors in patients with deep vein thrombosis Thromb Haemost 1999 82 6 1593 9
  34. Bucek RA Reiter M Quehenberger P Minar E Baghestanian M The role of soluble cell adhesion molecules in patients with suspected deep vein thrombosis Blood Coagul Fibrinolysis 2003 14 7 653 7
  35. Mosevoll KA Lindas R Tvedt TH Bruserud O Reikvam H Altered plasma levels of cytokines, soluble adhesion molecules and matrix metalloproteases in venous thrombosis Thromb Res 2015 136 1 30 9
  36. Rabinovich A Cohen JM Cushman M Inflammation markers and their trajectories after deep vein thrombosis in relation to risk of post-thrombotic syndrome J Thromb Haemost 2015 13 3 398 408
  37. Shbaklo H Holcroft CA Kahn SR Levels of inflammatory markers and the development of the post-thrombotic syndrome Thromb Haemost 2009 101 3 505 12
  38. Wells PS Anderson DR Rodger M Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis N Engl J Med 2003 349 13 1227 35
  39. Diaz JA Fuchs TA Jackson TO Plasma DNA is Elevated in Patients with Deep Vein Thrombosis J Vasc Surg Venous Lymphat Disord 2013 1 4 341 348.e1
  40. Weitz JI Fredenburgh JC Factors XI and XII as Targets for New Anticoagulants Front Med (Lausanne) 2017 4 19
  41. Salomon O Steinberg DM Zucker M Varon D Zivelin A Seligsohn U Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosis Thromb Haemost 2011 105 2 269 73
  42. Weitz JI Fredenburgh JC 2017 Scientific Sessions Sol Sherry Distinguished Lecture in Thrombosis: Factor XI as a Target for New Anticoagulants Arterioscler Thromb Vasc Biol 2018 38 2 304 10
  43. Myers D Wrobleski S Londy F New and effective treatment of experimentally induced venous thrombosis with anti-inflammatory rPSGLIg Thromb Haemost 2002 87 3 374 82
  44. Diaz JA Wrobleski SK Alvarado CM P-selectin inhibition therapeutically promotes thrombus resolution and prevents vein wall fibrosis better than enoxaparin and an inhibitor to von Willebrand factor Arterioscler Thromb Vasc Biol 2015 35 4 829 37
  45. Jilma B Kovar FM Hron G Homozygosity in the single nucleotide polymorphism Ser128Arg in the E-selectin gene associated with recurrent venous thromboembolism Arch Intern Med 2006 166 15 1655 9
  46. Jilma B Marsik C Kovar F Wagner OF Jilma-Stohlawetz P Endler G The single nucleotide polymorphism Ser128Arg in the E-selectin gene is associated with enhanced coagulation during human endotoxemia Blood 2005 105 6 2380 3
  47. Culmer DL Dunbar ML Hawley AE E-selectin inhibition with GMI-1271 decreases venous thrombosis without profoundly affecting tail vein bleeding in a mouse model Thromb Haemost 2017 117 6 1171 81
  48. Fuchs TA Brill A Wagner DD Neutrophil extracellular trap (NET) impact on deep vein thrombosis Arterioscler Thromb Vasc Biol 2012 32 8 1777 83
  49. Kimball AS Obi AT Diaz JA Henke PK The Emerging Role of NETs in Venous Thrombosis and Immunothrombosis Front Immunol 2016 7 236
  50. Dewyer NA El-Sayed OM Luke CE Divergent effects of Tlr9 deletion in experimental late venous thrombosis resolution and vein wall injury Thromb Haemost 2015 114 5 1028 37
  51. Deatrick KB Elfline M Baker N Postthrombotic vein wall remodeling: Preliminary observations J Vasc Surg 53 1 139 46
  52. Henke PK Mitsuya M Luke CE Toll-like receptor 9 signaling is critical for early experimental deep vein thrombosis resolution Arterioscler Thromb Vasc Biol 2011 31 1 43 9
  53. Deatrick KB Eliason JL Lynch EM Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model J Vasc Surg 2005 42 1 140 8
  54. Sood V Luke CE Deatrick KB Urokinase plasminogen activator independent early experimental thrombus resolution: MMP2 as an alternative mechanism Thromb Haemost 2010 104 6 1174 83
  55. Deatrick KB Obi A Luke CE Matrix metalloproteinase-9 deletion is associated with decreased mid-term vein wall fibrosis in experimental stasis DVT Thromb Res 2013 132 3 360 6
  56. Deatrick KB Luke CE Elfline MA The effect of matrix metalloproteinase 2 and matrix metalloproteinase 2/9 deletion in experimental post-thrombotic vein wall remodeling J Vasc Surg 2013 58 5 1375 1384 e1372
  57. Obi AT Diaz JA Farris DM Vitronectin Gene-deletion, PAI-1 Gene-deletion, and LMWH Treatment: Effect on Thrombus Resolution and Vein Wall Remodeling in a Mouse Model of DVT J Vasc Surg Venous Lymphat Disord 2013 1 1 103
  58. Baldwin JF Sood V Elfline MA The role of urokinase plasminogen activator and plasmin activator inhibitor-1 on vein wall remodeling in experimental deep vein thrombosis J Vasc Surg 2012 56 4 1089 97
  59. Obi AT Diaz JA Ballard-Lipka NL Plasminogen activator-1 overexpression decreases experimental postthrombotic vein wall fibrosis by a non-vitronectin-dependent mechanism J Thromb Haemost 2014 12 8 1353 63
  60. Hou H Ge Z Ying P Biomarkers of deep venous thrombosis J Thromb Thrombolysis 2012 34 3 335 46
  61. Matos MF Lourenco DM Orikaza CM Bajerl JA Noguti MA Morelli VM The role of IL-6, IL-8 and MCP-1 and their promoter polymorphisms IL-6 -174GC, IL-8 -251AT and MCP-1 -2518AG in the risk of venous thromboembolism: a case-control study Thromb Res 2011 128 3 216 20
  62. Wojcik BM Wrobleski SK Hawley AE Wakefield TW Myers DD Jr. Diaz JA Interleukin-6: a potential target for post-thrombotic syndrome Ann Vasc Surg 2011 25 2 229 39
  63. McInnes IB Thompson L Giles JT Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study Ann Rheum Dis 2015 74 4 694 702
Language: English
Page range: 173 - 181
Published on: Jul 1, 2018
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services

© 2018 Allan K. Metz, Jose A. Diaz, Andrea T. Obi, Thomas W. Wakefield, Daniel D. Myers, Peter K. Henke, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.